SPIRIVA® Respimat® : the only LAMA licensed as an add-on
treatment option for your uncontrolled asthma patients1

For use in adult asthma patients treated with a maintenance combination
of ICS (≥800 μg budesonide/day or equivalent) and a LABA and who
experienced ≥1 severe exacerbations in the previous year2

NHS list price of £23 for 30 days' treatment3

Intended for healthcare professionals only.

UK/SPRT-171026 June 2017

Prescribing information, adverse event reporting & references

SPIRIVA® Respimat®

the only LAMA licensed as
an add-on treatment option
for your uncontrolled
asthma patients1
For use in adult asthma patients treated
with a maintenance combination of ICS
(≥800 μg budesonide/day or equivalent)
and a LABA and who experienced
≥1 severe exacerbations in the
previous year2

Intended for healthcare professionals only.

UK/SPRT-171026 June 2017

Prescribing information, adverse
event reporting & references

Close X